ArticleCureus2024

Successful Treatment With Lorlatinib Monotherapy for Secondary Central Nervous System Oligometastatic Disease in Refractory Anaplastic Lymphoma Kinase Positive Non-small Cell Lung Cancer.

Hema Narlapati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.